Adrianne Neiss

Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials

Brian K. Albrecht, Victor Gehling, Michael C. Hewitt et al. · Journal of Medicinal Chemistry · 2016 · 214 citations · Full text

Immunology, Pharmacotherapy, Tumor Biology +22

miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma

Shyamal Dilhan Weeraratne, Vladimir Amani, Adrianne Neiss et al. · Neuro-Oncology · 2010 · 135 citations · Full text

Tumor Biology, Systems Biology, Positive Feedback Mechanism +13

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma

Andrew R. Conery, Richard C. Centore, Adrianne Neiss et al. · eLife · 2016 · 118 citations · Full text

Hematological Malignancy, Bromodomain Inhibition, Malignant Blood Disorder +9

Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma

Natalia Teider, Deborah K. Scott, Adrianne Neiss et al. · Neuro-Oncology · 2010 · 46 citations · Full text

Cell Death, Glioma, Tumor Biology +16

Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells

Sumati Gupta, Alexis Weston, Jared Bearrs et al. · Prostate Cancer and Prostatic Diseases · 2016 · 46 citations · Full text